Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

NCT02813252

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

NCT00042341

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Children's Hospital Los Angeles, California, United States
  • Children's Hospital Orange County, California, United States
  • Children's Hospital San Diego, California, United States
  • Children's Hospital Denver, Colorado, United States
View all 14 locations
View Trial Details
Completed

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

NCT02301156

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
  • TG Therapeutics Investigational Trial Site Chandler, Arizona, United States
  • TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
View all 88 locations
View Trial Details
Completed

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00416351

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details

Related conditions